Evidence map›Paper›PMID 39967351›Full record

ArticleJournal of medical virology2025

Integrated Seroprevalence and Genome-Based Study of SARS-CoV-2 Viral Strains in N'Djamena: Insights Into Chad's COVID-19 Epicenter.

Mathiew Hota, Andrillene L D Wondeu, Mahamat F Abakar, Koutaya Dezoumbe, Fatima Abdelrazakh, Sabrina Atturo, Nathan Naïbeï, Giulia Cappelli, Franck Mennechet, Fissou H Yandai and 22 more

Abstract read
In one paragraph

Article in Journal of medical virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Mathiew HotaDepartment of Laboratories, Ministry of Public Health, N'Djamena, Chad.
Andrillene L D WondeuLAGET Major Tropical Epidemics Laboratory, Bon Samaritain University Hospital, N'Djamena, Chad.
Mahamat F AbakarInstitut de Recherche en Elevage pour le Développement (IRED), N'Djamena, Chad.
Koutaya DezoumbeLAGET Major Tropical Epidemics Laboratory, Bon Samaritain University Hospital, N'Djamena, Chad.
Fatima AbdelrazakhInstitut de Recherche en Elevage pour le Développement (IRED), N'Djamena, Chad.
Sabrina AtturoLAGET Major Tropical Epidemics Laboratory, Bon Samaritain University Hospital, N'Djamena, Chad.
Nathan NaïbeïCommunity of Friends of Computing for Development "CAID-Tchad, N'Djamena, Chad.
Giulia CappelliInstitute for Biological Systems (ISB)-CNR, Monterotondo, Italy.
Franck MennechetUniversity of Montpellier, Pathogenesis and Control of Chronic an Emerging Infections (PCCEI), INSERM U1058, French Blood Establishment (EFS), Montpellier, France.
Fissou H YandaiDepartment of Laboratories, Ministry of Public Health, N'Djamena, Chad.
Djamal H AbdallahDepartment of Laboratories, Ministry of Public Health, N'Djamena, Chad.
Zongo R F EdgardOMS Tchad, Assistant Laboratoire COVID -19, N'Djamena, Chad.
Abdoulaye BoukarKing Faycal Hospital N'Djamena, N'Djamena, Chad.
Choroma A MoussaAbeché University Hospital Laboratory, Abeché, Chad.
Issa M YayaPMTCT/HIV Bol Health District, N'Djamena, Chad.
Mahamat I HamadBiltine Provincial Hospital, Biltine, Chad.
Nontegyol ArmandDoba Provincial Hospital, Doba, Chad.
Netalar HonorineMoundou Provincial Hospital, Moundou, Chad.
Kayanlengar FredericSarh Provincial Hospital, Sarh, Chad.
Adam A MoustaphaAti Provincial Hospital, Ati, Chad.
Yanda M DanielBongor Provincial Hospital, Bongor, Chad.
Adam M AlimPala Provincial Hospital, Pala, Chad.
Mahamat GreneMongo Provincial Hospital, Mongo, Chad.
Oumaima DjarmaDepartment of Infectious Diseases/National University Hospital of Reference, Université Bon Samaritain, N'Djamena, Chad.
Noubaramadji Y SuitombayeLAGET Major Tropical Epidemics Laboratory, Bon Samaritain University Hospital, N'Djamena, Chad.
Amine AkouyaLAGET Major Tropical Epidemics Laboratory, Bon Samaritain University Hospital, N'Djamena, Chad.
Ouchemi ChouaFaculty of Human Health Sciences, N'djamena University, N'djamena, Chad.
Guy R T DzomoLe Bon Samaritain University Hospital Complex, N'Djamena, Chad.
Djallaye DjimtoïbayeLAGET Major Tropical Epidemics Laboratory, Bon Samaritain University Hospital, N'Djamena, Chad.
Vittorio ColizziEvangelical University of Cameroon, Bandjoun, Cameroon.
Mahamat A MoussaFaculty of Human Health Sciences, N'djamena University, N'djamena, Chad.
Marta GiovanettiDepartment of Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, Roma, Italy.ORCID 0000-0002-5849-7326

Funding

The study was funded by the MAGIS foundation through the Italian Agency for Development Cooperation AID 04/Ciad/12022/202. Marta Giovanetti's funding is provided by PON "Ricerca e Innovazione" 2014-2020 and by the CRP-ICGEB RESEARCH GRANT 2020 Project CRP/BRA20-03, Contract CRP/20/03.
6 · The paper itself

Abstract

The COVID-19 epidemic has shown regional variations in transmission and outcomes. As a primary hotspot in Chad, N'Djamena is crucial for comprehensive epidemiological investigation. Our study employed two methodologies: seroprevalence data collection and whole-genome sequencing of SARS-CoV-2 strains. This dual approach assessed population exposure and virus genetic diversity. Seroprevalence data indicated broader exposure than confirmed cases suggested, and genome sequencing identified multiple strains, including globally recognized variants of concern. Integrating these data provided insights into transmission dynamics, potential herd immunity thresholds, and the impact of specific variants on disease progression. Our findings underscore the importance of integrated, multidisciplinary research in infectious disease epidemiology and inform targeted public health strategies, including social measures and vaccination, to combat infectious diseases in N'Djamena.

Indexed as

COVID-19Genome, ViralSARS-CoV-2AdolescentAdultAgedAntibodies, ViralChadFemaleGenetic VariationHumansMaleMiddle AgedSeroepidemiologic StudiesWhole Genome SequencingYoung AdultAntibodies, ViralChadgenomic surveillanceSARS‐CoV‐2seroprevalence

Identifiers

PMID39967351
PMCPMC11836593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.